echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > "14th Five-Year Plan" health development planning, health insurance payment reform and holding the Chinese medicine industry has a heart?

    "14th Five-Year Plan" health development planning, health insurance payment reform and holding the Chinese medicine industry has a heart?

    • Last Update: 2020-10-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Text . . . Code Wanxuan on the "500 varieties, to take the volume of procurement" rumors, mentioned a: category coverage, Chinese medicine should also be included.
    from the list circulating, there really is not much Chinese medicine in it.
    this confirms the consistent impression of the reform of the Chinese medicine industry, that is, "innovation is difficult, improvement is not easy, competition is disorderly, and the elimination is weak".
    worry that the catalogue has no place to pick, the sky dropped the next sticky bean bag.
    Recently, a study on the scientific and technological competitiveness of chinese medicine varieties (2019 edition) launched by the private sector selected the top 579 varieties from the three dimensions of "clinical value, scientific value and market value" and from the 59,595 traditional Chinese medicine products that have been listed.
    is a product-based leaderboard, but individual enterprises can occupy the list of different varieties, it can be seen that both have a certain advertising nature.
    this in the market, there is nothing wrong with it, and it does not affect our multi-angle reference, thinking.
    this article, we start from this list, to explore chinese medicine, traditional Chinese medicine price changes.
    The 14th Five-Year Plan for Health Development made the Chinese medicine industry take the heart-stopping pills on September 22, General Secretary Xi Jinping presided over a symposium of experts in the field of education, culture, health and sports and delivered an important speech to listen to opinions and suggestions on economic and social development during the 14th Five-Year Plan period. In the draft issued after the
    meeting, the third of the nine key tasks is "to promote the innovation and development of Chinese medicine heritage, adhere to the chinese and Western medicine and complement each other's advantages, establish a service system, service model, personnel training model in line with the characteristics of Chinese medicine, to play the unique advantages of Chinese medicine."
    article 9 of the Basic Health Care and Health Promotion Law, which was implemented on June 1, states that the state will vigorously develop the cause of Chinese medicine, adhere to the combination of Chinese and Western medicine, heritage and innovation, and give full play to the unique role of Chinese medicine in the cause of health care and health.
    we can think that the current period is a great time for the inheritance and development of Chinese medicine and the re-development of the market.
    At the same time, however, we need to recognize two facts: First, by the impact of the drug belt procurement mechanism, the clinical use of chemical generic drugs has increased significantly, the proportion of potential growth trends.
    the procurement mechanism for pharmaceutical companies, pharmaceutical industry, is taking place from harming a small number of enterprises, product monopoly interests to help the entire track, the industry to reshape the market efficiency of the phenomenon changes.
    Second, in the new medical reform track of the three doctors, Chinese medicine and graded diagnosis and treatment system, modern hospital management system, universal medical insurance system, drug supply guarantee system, comprehensive supervision system can not be broken apart, but at present, it is urgent to play more influence, need to catch up.
    From a list of traditional Chinese medicine to see the overall development of the Chinese medicine industry first, at least these 579 large varieties of traditional Chinese medicine into a list, indicating that the size of the Chinese medicine industry is still enough, the enterprise power is very active.
    In our view, there are some subtle characteristic differences between Chinese medicine (including Chinese medicine injections), Chinese medicine tablets, Chinese medicine particles: Chinese medicine is more standard finished product properties, Chinese medicine drink tablets are a bit like supplies, Chinese medicine particles show packaging form innovation and raw material temperament.
    , Chinese medicine is also facing plate competition within the Chinese medicine industry.
    other hand, in the sub-sector of Chinese medicine, there may be shortage of Chinese medicine in addition to these 579 large varieties.
    second, in the internal ranking of Chinese medicine and even Chinese medicine industry, there should be some linkage in the three dimensions of scientific value, clinical value and market value.
    in our view, scientific value and clinical value are mutually certified, both of which together provide great support for market value.
    , chinese medicine and even Chinese medicine prescriptions rely more on the medical department's use of introduction and risk guarantee.
    , the Chinese medicine sector should bear the pressure of "difficult innovation, difficult improvement, disorderly competition and weak elimination".
    the other hand, Chinese medicine enterprises should play the sprint power of operation, the policy does not restrict market competition, welcome price competition.
    , in the Chinese traditional medicine and even the Chinese medicine industry, medicine business, medical services and other follow-up circulation, use links, has a more comprehensive voice and even pricing power.
    In our view, on the one hand, the circulation of Chinese medicine industry is more important than chemical and biological drugs, related pharmaceutical business, medical services as long as there is goodwill, often a lot of premium.
    in other words, with volume procurement on the Chinese medicine industry did not treat other drug classification so well.
    without the purchase of traditional Chinese medicine belt, it is difficult to appear a single variety of clinical large-volume, chinese medicine and traditional Chinese medicine combined to play a role in facing a steep environment.
    , on the other hand, the Chinese medicine industry can move to over-the-counter drugs.
    The first thing that needs to be clarified by the reform of the scope, mode of payment and standard of payment of health insurance is that, with the concept of natural extracts and their limited combinations, some chinese medicines are relatively suitable for the development of over-the-counter drugs, perhaps without the need to use the medical insurance drug market to expand.
    well known that the current coverage of health insurance payments for over-the-counter drugs, especially Class B over-the-counter drugs, there is a tightening pressure and exclusion trend.
    , however, looking ahead, even in an era when medicare no longer pays for over-the-counter medicines, it is still possible to open up a network of over-the-counter Chinese medicines because of Chinese medicine. one of the
    reasons: Article 85 of the Basic Medical and Health Promotion Law clearly states that the competent department of medical security under the State Council shall conduct evidence-based medical and economic evaluation of the list of essential medical insurance drugs, medical treatment projects, standards of medical service facilities and other organizations included in the scope of payment, and shall listen to the opinions of the competent departments of health and health under the State Council, the competent departments of Chinese medicine, the drug supervision and administration departments and the financial departments.
    evaluation should be used as the basis for adjusting the scope of payment of the basic medical insurance fund.
    in the level of medical insurance payment methods, from the Chinese medicine in the treatment of the new crown pneumonia epidemic, we are optimistic that Chinese medicine in the inpatient and outpatient medical insurance payment scenario occupies a certain position.
    Regardless of the pay-per-disease (e.g., the advantages of Chinese medicine), pay-per-person, pay-per-project, etc., the classification of Traditional Chinese medicine represented by traditional Chinese medicine, the combination of medicine featuring Traditional Chinese medicine may play a lower advantage over the total cost, thereby enhancing the impact in clinical applications and attracting patients.
    it has been observed that Chinese medicine has certain advantages in the treatment of common/chronic diseases and preventive health care in an old and small medical insurance population, in the drug-using groups during the prevention and control of the epidemic.
    can be seen that the payment method to support the development of Chinese medicine is bound to be closely combined with the efficient nature of management, and must be projected as the affordable payment standard of the medical insurance fund and the level of fees acceptable to patients.
    this will inevitably need to standardize the diagnosis and treatment program, the implementation of rational drug use, will inevitably promote the regional general Chinese medicine teacher system landing and the emergence of online red Chinese medicine.
    In order to do a good job in the cause of Traditional Chinese medicine, we recommend: First, to give full play to the influence and service value of Traditional Chinese medicine, the implementation of national and local development plans;
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.